Fully percutaneous vs. surgical transfemoral TAVR: similar major vascular complications rate and shorter hospital stay.

Original title: Factors associated with vascular complications in patients undergoing balloon-expandable transfemoral transcatheter aortic valve replacement via open versus percutaneous approaches. Reference: Kadakia MB et al. Circ Cardiovasc Interv. 2014; Epub ahead of print.

 

This retrospective study included 331 patients undergoing transfemoral TAVR in one center between 2007 and 2013. 64% of the population were treated with the fully percutaneous approach and the rest via the open surgical approach. Only the Edwards valve was employed (Sapien o Sapien XT).

At baseline, patients in the open surgical group presented major heart disease, previous infarction, chronic renal failure, worse functional class and higher STS score (11.1 vs 9.1; p=0.007). Those treated with fully percutaneous approach presented shorter length of stay (7.7 vs 9.9 days; p=0.003) and fewer vascular complications at 30 days (11% vs 20%: p=0.03).

The most common complications in both groups were iliofemoral perforation and iliofemoral dissection. There was no difference in all-cause in-hospital mortality between the groups.

After propensity score matching, on account of the different baseline characteristics, each group had 112 patients. The difference in major vascular complications disappeared (13% vs 15%; p=0.7) but the advantage of the fully percutaneous approach as regards hospital stay length remained (7.9 ± 5.5 days vs 10.0 ± 10.1; p=0.04).

The multivariable analysis showed 2 predictors of overall vascular complications: female sex (OR 2.2; IC 95% 1.1 a 4.3) and sheath oversizing (per 1 mm increase in the difference between sheath outer diameter and minimal artery diameter; OR 1.4; IC 95% 1.1 to 1.8).

Conclusion

Fully percutaneous TAVR was associated with a similar vascular complications risk and a significant shorter hospital stay compared to open surgical TAVR. Sheath oversizing (with respect to artery diameter), and female sex were associated to vascular complications, despite the approach.

Editorial Comment

Technological advances will continue to reduce sheath size, which in turn will reduce vascular complications. However, in the individual patient, outcomes will depend on careful planning, since sheath oversizing is the strongest predictor of vascular complications. 

A shorter hospital stay and a similar vascular complications rate makes the percutaneous approach the ideal technique; however, closure device cost vs. hospital cost should always be pondered on account of the different contexts in different countries. 

SOLACI.ORG

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...